Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Colchicine

    Virtual Booth

    Contact Supplier

    Colchicine

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Colchysat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,335Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Micro’s Generics Colchicine Receives Approval in US
    Micro’s Generics Colchicine Receives Approval in US

    17 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212880

    FDA
    17 Feb 2026
    Share Share
    Macleods Pharms’ Generics Colchicine Receives Approval in US
    Macleods Pharms’ Generics Colchicine Receives Approval in US

    13 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210633

    FDA
    13 Feb 2026
    Share Share
    Scilex Publishes Gloperba Dosing Update in Journal
    Scilex Publishes Gloperba Dosing Update in Journal

    05 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/05/3094624/0/en/Scilex-Holding-Company-Announces-Publication-on-GLOPERBA-Dosing-Adjustments-in-Peer-Review-Journal.html

    GLOBENEWSWIRE
    05 Jun 2025
    Share Share
    Scilex Gets Orphan Drug Nod for Colchicine in Pericarditis
    Scilex Gets Orphan Drug Nod for Colchicine in Pericarditis

    16 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/16/3062839/0/en/Scilex-Holding-Company-Announces-FDA-Has-Approved-Our-Request-for-the-Orphan-Drug-Designation-for-Colchicine-for-the-Treatment-of-Pericarditis.html

    GLOBENEWSWIRE
    16 Apr 2025
    Share Share
    ACC: Low-Dose Colchicine Reduces Coronary Plaque Progression
    ACC: Low-Dose Colchicine Reduces Coronary Plaque Progression

    31 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250331819019/en/Late-Breaking-Clinical-Trial-Presented-at-the-American-College-of-Cardiology-Supports-Low-Dose-Colchicine-0.5-mg-to-Treat-Cardiovascular-Disease-by-Reducing-Progression-of-Coronary-Plaque

    BUSINESSWIRE
    31 Mar 2025
    Share Share
    Enforcement Report - Week of January 15, 2025
    Enforcement Report - Week of January 15, 2025

    15 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-15-2025-7287.pdf

    FDA
    15 Jan 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.